TrialAnnals of oncology : official journal of the European Society for Medical Oncology2020

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.

A K McMillan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.